152 related articles for article (PubMed ID: 32355538)
1. Promising diagnostic and prognostic value of six genes in human hepatocellular carcinoma.
Zhang G; Kang Z; Mei H; Huang Z; Li H
Am J Transl Res; 2020; 12(4):1239-1254. PubMed ID: 32355538
[TBL] [Abstract][Full Text] [Related]
2. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
3. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
4. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
[TBL] [Abstract][Full Text] [Related]
6. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang WX; Pan YY; You CG
Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
[TBL] [Abstract][Full Text] [Related]
7. Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma.
Li C; Xu J
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32046048
[TBL] [Abstract][Full Text] [Related]
8.
Lin T; Zhang Y; Lin Z; Peng L
Int J Gen Med; 2021; 14():7487-7501. PubMed ID: 34744456
[TBL] [Abstract][Full Text] [Related]
9. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.
Wang M; Wang L; Wu S; Zhou D; Wang X
Int J Genomics; 2019; 2019():3518378. PubMed ID: 31886163
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of X-Ray Repair Cross-Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma.
Mei J; Wang H; Wang R; Pan J; Liu C; Xu J
Biomed Res Int; 2020; 2020():5751939. PubMed ID: 32258128
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
Li Z; Xu J; Cui H; Song J; Chen J; Wei J
Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
[TBL] [Abstract][Full Text] [Related]
12. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
[TBL] [Abstract][Full Text] [Related]
13. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
[TBL] [Abstract][Full Text] [Related]
14. [Bioinformatics Analysis of Hepatocellular Carcinoma Related Gene and Construction of a Protein-Protein Interaction Network].
Cao D; Yu L; Wang LC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 49(6):899-903. PubMed ID: 32677401
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
16. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
17. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
18. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
19. Comprehensive Analysis of the Expression and Prognosis for Lipid Metabolism-Related Genes in Hepatocellular Carcinoma.
Fan WJ; Ding H; Chen XX; Yang L
South Asian J Cancer; 2023 Apr; 12(2):126-134. PubMed ID: 37969675
[TBL] [Abstract][Full Text] [Related]
20. Exploration of Prognostic Biomarkers among Replication Factor C Family in the Hepatocellular Carcinoma.
Deng J; Zhong F; Gu W; Qiu F
Evol Bioinform Online; 2021; 17():1176934321994109. PubMed ID: 33628006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
